EQUITY ALERT: Rosen Law Firm Announces Investigation of Penford Corporation Concerning its Proposed Sale to Ingredion Incorporated

The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Penford Corporation (NASDAQ:PENX) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Penford to maximize shareholder value before agreeing to be acquired by Ingredion Incorporated (NYSE:INGR).

If you would like to join the action, go to http://rosenlegal.com/cases-400.html or contact Phillip Kim or Kevin Chan, toll-free at 866-767-3653, or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com. There is no cost or obligation to you.

Under the terms of the proposed transaction, shareholders will receive $19.00 in cash for each share of Penford they own. The proposed transaction is valued at approximately $340 million. The investigation relates to whether the proposal for $19.00 in cash per share in cash is fair to public shareholders and whether Penford’s Board breached its fiduciary duties in connection with the proposed sale.

If you currently own shares of Penford and wish to obtain additional information, please visit the website at http://rosenlegal.com/cases-400.html. You may also contact Phillip Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts:

Phillip Kim, Esq.
Kevin Chan, Esq.
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
pkim@rosenlegal.com
kchan@rosenlegal.com
lrosen@rosenlegal.com
www.rosenlegal.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.